Joseph C. Scodari's most recent trade in Acurx Pharmaceuticals Inc was a trade of 24,631 Warrants for Common Stock done . Disclosure was reported to the exchange on Jan. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals Inc | Joseph C. Scodari | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Jan 2025 | 24,631 | 24,631 | - | - | Warrants for Common Stock | |
| Acurx Pharmaceuticals Inc | Joseph C. Scodari | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 06 Jan 2025 | 24,631 | 27,708 | - | 1.0 | 25,000 | Common Stock |
| Acurx Pharmaceuticals Inc | Joseph C. Scodari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 12,000 | 12,000 | - | - | Stock Option | |
| OptiNose Inc | Joseph C. Scodari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Acurx Pharmaceuticals Inc | Joseph C. Scodari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option | |
| OptiNose Inc | Joseph C. Scodari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 14,439 | 14,439 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Joseph C. Scodari | Director | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 10 May 2021 | 10,000 | 31,230 (0%) | 0% | 3.0 | 29,900 | Common Stock |